bioAffinity Technologies, Inc. share price logo

bioAffinity Technologies, Inc.

NASDAQ: BIAF

$7.93

+0.10

(+1.28%)

as on

bioAffinity Technologies, Inc. Stock Performance

as on September 26, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $7.69
    $7.96
    downward going graph

    3.03%

    Downside

    0.38%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.56
    $109.35
    downward going graph

    42.50%

    Downside

    1278.94%

    Upside

    downward going graph

bioAffinity Technologies, Inc. share price movements today

Previous Close
$7.83
Open
$7.71
Volume
370.3K
Market Cap
$4.7M
Day's Low - High
$7.69 - $7.96
52 Week Low - High
$4.56 - $109.35

bioAffinity Technologies, Inc. Historical Returns

1 Month Return
+ 55.8 %
3 Month Return
-36.31 %
1 Year Return
-90.01 %
3 Year Return
-98.38 %
5 Year Return
0 %

bioAffinity Technologies, Inc. Stock Fundamentals & Key Indicators

Check bioAffinity Technologies, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.7M

EPS (TTM)

-120.15

Dividend Yield

0.00%

PE Ratio (TTM)

-0.07

Industry PE ratio

-4.20

PEG Ratio

-0.0006192362968030047

Return On Equity TTM

-257.27%

bioAffinity Technologies, Inc. Stock Valuation

Track how bioAffinity Technologies, Inc. P/E has moved over time to understand its valuation trends.

bioAffinity Technologies, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-9.68x)

December 31, 2021

Industry (-4.20x)

December 31, 2025

Today (-0.14x)

December 31, 2025

Highest (-0.14x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.14x

bioAffinity Technologies, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of bioAffinity Technologies, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
bioAffinity Technologies, Inc. image
bioAffinity Technologies, Inc.
NA$4.7MNA-0.07-39.57%0.00%
Natera image
Natera
StrongBuy$56.3B246.08%-287.3565.30%0.00%
Agilent image
Agilent
StrongBuy$47.2B0.23%33.9653.73%0.49%
Thermo Fisher image
Thermo Fisher
StrongBuy$243.5B10.7%36.4341.03%0.28%
Danaher image
Danaher
StrongBuy$155.4B-30.82%39.6158.51%0.65%

Stock Returns calculator for bioAffinity Technologies, Inc. Stock including INR - Dollar returns

The bioAffinity Technologies, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

bioAffinity Technologies, Inc. investment value today

Current value as on today

₹10,799

Returns

-₹89,201

(-89.2%)

Returns from bioAffinity Technologies, Inc. Stock

-₹90,006 (-90.01%)

Dollar Impact

₹805 (+0.81%)

Indian Investors' Interest in bioAffinity Technologies, Inc. Stock

Investment in bioAffinity Technologies, Inc. Shares on INDmoney has grown by 596.92% in the last 30 days, indicating increased investment activity.

Time period: to

Change:596.92% versus previous 30 day period

Search interest for bioAffinity Technologies, Inc. Stock has increased by 1095% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1095% versus previous 30 day period

bioAffinity Technologies, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
2
2
2
1
1
1
1
1
1
Gross Profit
0
0
0
0
0
0
0
0
0
-3
Operating Income
-2
-1
-2
-1
-2
-2
-2
-3
-3
-3
EBITDA
-2
-1
-1
-1
-2
-3
-4
-2
-3
-3
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-1
-2
-1
-2
-4
-5
-3
-3
-3
Income Tax Expense
0
0
0
0
0
0
0
0
-
-
Net Income
-2
-1
-2
-2
-2
-4
-5
-3
-3
-3
Net Profit Margin
74.97%
34.61%
41.29%
38.73%
26.21%
19.92%
27.00%
18.91%
22.82%
-220.77%

bioAffinity Technologies, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Dec 2025
Total Revenue
-
-
-
0
2
9
6
Gross Profit
0
0
0
0
0
3
1
Operating Income
-3
-2
-2
-4
-7
-8
-10
EBITDA
-3
-6
-5
-5
-7
-8
-14
Interest Expense
0
0
1
2
0
0
0
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-3
-7
-6
-8
-7
-9
-14
Income Tax Expense
0
0
0
0
0
0
0
Net Income
-3
-7
-6
-8
-7
-9
-14
Net Profit Margin
0.00%
0.00%
0.00%
90.28%
31.26%
36.09%
23.21%

bioAffinity Technologies, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-1
-2
-2
-2
-4
-5
-3
-3
-3
Operating Cash Flow
-1
-2
-1
-1
-1
-2
-2
-2
-3
-3
Investing Cash Flow
-2
0
0
0
0
0
0
-
0
0
Financing Cash Flow
0
2
0
1
1
3
9
1
0
2
Change in Cash
-3
0
-1
0
0
0
6
-1
-3
0

bioAffinity Technologies, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Dec 2025
Net Income
-3
-7
-6
-8
-7
-9
-14
Operating Cash Flow
-2
-2
-2
-4
-6
-7
-9
Investing Cash Flow
0
0
-
0
-2
0
0
Financing Cash Flow
2
1
3
14
0
5
14
Change in Cash
0
0
1
10
-8
-1
5

Mutual Funds that own bioAffinity Technologies, Inc. Stock

Check out the Mutual Funds with significant holdings in bioAffinity Technologies, Inc..

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
4.760998%
55543
Fidelity Concord Street Trust
3.019393%
35225
DFA INVESTMENT DIMENSIONS GROUP INC
1.259444%
14693

Global Institutional Holdings in bioAffinity Technologies, Inc.

Funds
Holdings
VANGUARD INDEX FUNDS
4.76%
Fidelity Concord Street Trust
3.02%
DFA INVESTMENT DIMENSIONS GROUP INC
1.26%
Dimensional
0.34%
Vanguard
0.32%

bioAffinity Technologies, Inc. News & Key Events

  • img

    Today's Timeline - 17 September

    Thu, 06:29 PM

    -

    bioAffinity secures Hong Kong patent for CyPath Lung, enhancing its IP protection in Asia for lung cancer diagnostics.

Insights on bioAffinity Technologies, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.35M → 1.51M (in $), with an average increase of 10.5% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -3.63M → -3.36M (in $), with an average increase of 7.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BIAF stock has moved up by 56.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 784.9% return, outperforming this stock by 883.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 153.2% return, outperforming this stock by 243.2%

About bioAffinity Technologies, Inc.

As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
OrganisationbioAffinity Technologies, Inc.
Headquarters3300 Nacogdoches Road, San Antonio, TX, 78217, US
IndustryMedical - Diagnostics & Research
CEOMaria Zannes
E-voting on sharesClick here to vote

Key Management of bioAffinity Technologies, Inc.

Name

Title

Dr. William Bauta Ph.D.

Chief Science Officer

Mr. Timothy P. Zannes J.D.

Executive VP, Secretary & General Counsel

Ms. Julie Anne Overton

Director of Communications

Mr. Steven Girgenti

Founder & Executive Chairman of the Board

Ms. Maria Zannes J.D.

Founder, President, CEO & Director

Mr. James Michael Edwards CPA, M.B.A.

Chief Financial Officer

Mr. Xavier T. Reveles M.S.

Chief Operating Officer

Mr. Dallas J. Coleman

Vice President of sales

Dr. Gordon Downie M.D., Ph.D.

Chief Medical Officer

FAQs

What is bioAffinity Technologies, Inc. share price today?

bioAffinity Technologies, Inc. share price today is $7.93 as on at the close of the market. bioAffinity Technologies, Inc. share today touched a day high of $7.96 and a low of $7.69.

What is the 52 week high and 52 week low for bioAffinity Technologies, Inc. share?

bioAffinity Technologies, Inc. share touched a 52 week high of $109.35 on and a 52 week low of $4.56 on . bioAffinity Technologies, Inc. stock price today i.e. is closed at $7.93,which is 92.75% down from its 52 week high and 73.90% up from its 52 week low.

What is bioAffinity Technologies, Inc.'s market capitalisation today?

bioAffinity Technologies, Inc. market capitalisation is $0.00T as on .

How to invest in bioAffinity Technologies, Inc. Stock (BIAF) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for bioAffinity Technologies, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in bioAffinity Technologies, Inc. Shares that will get you 0.1892 shares as per bioAffinity Technologies, Inc. share price of $7.93 per share as on September 26, 2026 at 8:46 am IST.

What is the minimum amount required to buy bioAffinity Technologies, Inc. Stock (BIAF) from India?

Indian investors can start investing in bioAffinity Technologies, Inc. (BIAF) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in bioAffinity Technologies, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on bioAffinity Technologies, Inc. share’s latest price of $7.93 as on September 26, 2026 at 8:46 am IST, you will get 1.2610 shares of bioAffinity Technologies, Inc.. Learn more about fractional shares .